Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03923153
Other study ID # MustafaKU 2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 15, 2019
Est. completion date August 30, 2020

Study information

Verified date May 2021
Source Mustafa Kemal University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Stable angina is a cardiac pathology that adversely affects the quality of life of the patient, which develops as a result of narrowing of the coronary vessels developing in atherosclerotic ground and / or impaired oxygen supply-need balance. Studies widely investigated the effects of exercise training in patients with stable angina. No study investigated the effects of inspiratory muscle training in patients with stable angina.Investigators aimed to investigate the effects of inspiratory muscle training on aerobic exercise capacity, quality of life, depression, peripheral and respiratory (MIP, MEP) muscle strength, pulmonary function, dyspnea, fatigue in stable angina patients.


Description:

Patients with stable angina will be included. Primary outcome measurement is inspiratory muscle strength, secondary outcomes are functional exercise capacity, peripheral muscle strength, pulmonary functions, maximal exercise capacity, fatigue, quality of life, depression.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 30, 2020
Est. primary completion date August 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - No contraindication for pulmonary physiotherapy - Anjina patients who are clinically stable - have no other disease that may affect respiratory function - Individuals who have the good cooperation Exclusion Criteria: - Patients under the age of 18 - Pregnancy - Active infection - Patients with known malignancies - patients without consent - known arrhythmia, dilated or hypertrophic cardiomyopathy, heart failure (EF <40%)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Inspiratory muscle training with PowerBreathe (IMT Technologies Ltd., Birmingham,England)
Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 30% of maximal inspiratory pressure (MIP). The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload. The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.
Sham group with PowerBreathe (IMT Technologies Ltd., Birmingham, England)
Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 10% of maximal inspiratory pressure (MIP). The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload. The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.

Locations

Country Name City State
Turkey Hatay Mustafa Kemal University Hatay Merkez

Sponsors (1)

Lead Sponsor Collaborator
Mustafa Kemal University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624. — View Citation

Kellens I, Cannizzaro F, Gouilly P, Crielaard JM. [Inspiratory muscles strength training in recreational athletes]. Rev Mal Respir. 2011 May;28(5):602-8. doi: 10.1016/j.rmr.2011.01.008. Epub 2011 Apr 19. French. — View Citation

Long L, Anderson L, Dewhirst AM, He J, Bridges C, Gandhi M, Taylor RS. Exercise-based cardiac rehabilitation for adults with stable angina. Cochrane Database Syst Rev. 2018 Feb 2;2:CD012786. doi: 10.1002/14651858.CD012786.pub2. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Quality life Change of baseline quality of life at 8 week .Short Form (SF-36) Health Survey (Turkish version of scale) The SF-36 is a 36 item questionnaire that measures eight multi-item dimensions of health: physical functioning (10 items) social functioning (2 items) role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items). For each dimension item scores are coded, summed, and transformed on to a scale from 0 (worst possible health state measured by the questionnaire) to 100 (best possible health state). Baseline, after 8 week
Primary Change of the Inspiratory and expiratory muscle strength (MIP, MEP) from baseline to 8 week Mouth pressure device( MicroRPM, Micro Medical England) Baseline, after 8 week
Secondary Change from Baseline Functional exercise capacity at 8 week 6 minute walking test Baseline, after 8 week
Secondary Change from Pulmonary functions at 8 week Spirometry Baseline, after 8 week
Secondary Fatigue Change from baseline Fatigue Severity Scale (FSS) (Turkish version of scale) at 8 weeek.
Patient choose a number from 1 to 7 that indicates how much the patient agrees with each statement, where 1 indicates strong disagreement and 7 indicates strong agreement. A score of 4 or higher generally indicates severe fatigue
Baseline, after 8 week
Secondary Depression Change from baseline Montgomery Asberg Depression Rating Scale (MADRS) (Turkish version of scale) at 8 week.
This assessment tool contains 10 items with a score from 0 to 6, thus the maximum score is 60. A higher score indicates a more severe depression.
Baseline,after 8 week
See also
  Status Clinical Trial Phase
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Recruiting NCT02870764 - The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Phase 4
Completed NCT04648306 - Restore EF Observational Study
Recruiting NCT05933083 - MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation N/A
Not yet recruiting NCT02280850 - Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina Phase 4
Completed NCT04785846 - Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.
Completed NCT03759067 - Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients N/A
Not yet recruiting NCT03306550 - Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin N/A
Completed NCT03193294 - CORonary MICrovascular Angina (CorMicA) N/A
Completed NCT04131816 - HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program N/A
Recruiting NCT06075602 - COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
Recruiting NCT03783351 - Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE) N/A
Recruiting NCT06464042 - Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease
Not yet recruiting NCT05857904 - Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain N/A
Recruiting NCT01838148 - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
Terminated NCT02914834 - Acupuncture for Individuals With Stable Angina N/A
Recruiting NCT05825339 - Absolute Flow for Ischemia With No Obstructive Coronary Arteries
Completed NCT05804500 - RecoveryPlus Telerehab Platform Pilot Study N/A
Completed NCT03518645 - Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds N/A
Terminated NCT01550614 - Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease Phase 3